Literature DB >> 11021834

Synaptic vesicle protein 2, A new neuroendocrine cell marker.

G M Portela-Gomes1, A Lukinius, L Grimelius.   

Abstract

Synaptic vesicle protein 2 (SV2) is a glycoprotein identified in the nervous system of several species, including man, but its occurrence in the human neuroendocrine (NE) cell system has not been investigated. By using a monoclonal antibody to SV2, immunoreactivities were demonstrated in NE cell types in human gastrointestinal tract, pancreas, anterior pituitary gland, thyroid, parathyroid, and adrenal medulla, and also in chief cells of gastric oxyntic mucosa. Immunoelectron microscopy of pancreatic islets revealed SV2 immunoreactivity in secretory granules. Comparison of SV2, synaptophysin, and chromogranin A immunoreactivity showed more SV2- and synaptophysin- than chromogranin A-immunoreactive cells in the antrum and pancreas. In the other gastrointestinal regions and in the other endocrine organs more SV2- than synaptophysin-immunoreactive cells were seen. More chromogranin A- than SV2-immunoreactive cells were observed in duodenum, colon, and parathyroid. Various NE tumors were examined and all contained SV2-immunoreactive cells. The staining patterns with the three markers agreed well, except in hindgut carcinoids, which showed strong SV2 immunoreactivity, weak synaptophysin but no chromogranin A immunostaining. In pituitary adenomas more cells were immunoreactive to SV2 than to the other two antibodies. In conclusion, SV2 is recognized as a further broad marker for NE cells and widens the arsenal of diagnostic tools for NE tumors. It is of special importance for identifying hindgut carcinoids.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11021834      PMCID: PMC1850151          DOI: 10.1016/S0002-9440(10)64645-7

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  30 in total

1.  The synaptic vesicle protein SV2 is a novel type of transmembrane transporter.

Authors:  M B Feany; S Lee; R H Edwards; K M Buckley
Journal:  Cell       Date:  1992-09-04       Impact factor: 41.582

2.  Co-localization of islet amyloid polypeptide and insulin in the B cell secretory granules of the human pancreatic islets.

Authors:  A Lukinius; E Wilander; G T Westermark; U Engström; P Westermark
Journal:  Diabetologia       Date:  1989-04       Impact factor: 10.122

3.  A 38,000-dalton membrane protein (p38) present in synaptic vesicles.

Authors:  R Jahn; W Schiebler; C Ouimet; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

4.  Catalyzed reporter deposition, a novel method of signal amplification. Application to immunoassays.

Authors:  M N Bobrow; T D Harris; K J Shaughnessy; G J Litt
Journal:  J Immunol Methods       Date:  1989-12-20       Impact factor: 2.303

5.  Ultrastructural localization of synaptophysin to the secretory granules of normal glucagon and insulin cells in human islets of Langerhans.

Authors:  M Kalina; A Lukinius; L Grimelius; A Höög; S Falkmer
Journal:  Ultrastruct Pathol       Date:  1991 May-Jun       Impact factor: 1.094

6.  Synaptophysin immunoreactivity and small clear vesicles in neuroendocrine cells and related tumours.

Authors:  R Buffa; G Rindi; F Sessa; A Gini; C Capella; R Jahn; F Navone; P De Camilli; E Solcia
Journal:  Mol Cell Probes       Date:  1987-12       Impact factor: 2.365

7.  Identification of gastroenteropancreatic neuroendocrine cells in normal and neoplastic human tissue with antibodies against synaptophysin, chromogranin A, secretogranin I (chromogranin B), and secretogranin II.

Authors:  B Wiedenmann; R Waldherr; H Buhr; A Hille; P Rosa; W B Huttner
Journal:  Gastroenterology       Date:  1988-11       Impact factor: 22.682

8.  Identification and localization of synaptophysin, an integral membrane glycoprotein of Mr 38,000 characteristic of presynaptic vesicles.

Authors:  B Wiedenmann; W W Franke
Journal:  Cell       Date:  1985-07       Impact factor: 41.582

9.  Distribution of somatostatin-14 and somatostatin-28 gastrointestinal-pancreatic cells of rats and humans.

Authors:  B H Francis; D G Baskin; D R Saunders; J W Ensinck
Journal:  Gastroenterology       Date:  1990-11       Impact factor: 22.682

10.  Endocrine secretory granules and neuronal synaptic vesicles have three integral membrane proteins in common.

Authors:  A W Lowe; L Madeddu; R B Kelly
Journal:  J Cell Biol       Date:  1988-01       Impact factor: 10.539

View more
  27 in total

1.  Yapsin 1 immunoreactivity in {alpha}-cells of human pancreatic islets: implications for the processing of human proglucagon by mammalian aspartic proteases.

Authors:  Niamh X Cawley; Guida Portela-Gomes; Hong Lou; Y Peng Loh
Journal:  J Endocrinol       Date:  2011-06-01       Impact factor: 4.286

2.  Vagal innervation of the air sacs in a songbird, Taenopygia guttata.

Authors:  M Fabiana Kubke; Jacqueline M Ross; J Martin Wild
Journal:  J Anat       Date:  2004-04       Impact factor: 2.610

Review 3.  Immunohistochemical and biochemical studies with region-specific antibodies to chromogranins A and B and secretogranins II and III in neuroendocrine tumors.

Authors:  Guida M Portela-Gomes; Lars Grimelius; Mats Stridsberg
Journal:  Cell Mol Neurobiol       Date:  2010-11-03       Impact factor: 5.046

Review 4.  Immunohistochemical Biomarkers of Gastrointestinal, Pancreatic, Pulmonary, and Thymic Neuroendocrine Neoplasms.

Authors:  Silvia Uccella; Stefano La Rosa; Marco Volante; Mauro Papotti
Journal:  Endocr Pathol       Date:  2018-06       Impact factor: 3.943

5.  Expression of amino acid sequences of the chromogranin A molecule and synaptic vesicle protein 2 in neuroendocrine tumors of the lung.

Authors:  Guida Maria Portela-Gomes; Lars Grimelius; Mats Stridsberg; Enrica Bresaola; Giuseppe Viale; Giuseppe Pelosi
Journal:  Virchows Arch       Date:  2005-05-20       Impact factor: 4.064

Review 6.  Synaptic vesicle protein 2: A multi-faceted regulator of secretion.

Authors:  Kristine Ciruelas; Daniele Marcotulli; Sandra M Bajjalieh
Journal:  Semin Cell Dev Biol       Date:  2019-03-21       Impact factor: 7.727

7.  Overexpression of ODF1 in Gastrointestinal Tract Neuroendocrine Neoplasms: a Novel Potential Immunohistochemical Biomarker for Well-differentiated Neuroendocrine Tumors.

Authors:  Baicheng Li; Xinjun Li; Ruiqi Mao; Min Liu; Limei Fu; Lifang Shi; Songlin Zhao; Mingxia Fu
Journal:  Endocr Pathol       Date:  2020-09-01       Impact factor: 3.943

8.  Evaluation of PET Brain Radioligands for Imaging Pancreatic β-Cell Mass: Potential Utility of 11C-(+)-PHNO.

Authors:  Jason Bini; Mika Naganawa; Nabeel Nabulsi; Yiyun Huang; Jim Ropchan; Keunpoong Lim; Soheila Najafzadeh; Kevan C Herold; Gary W Cline; Richard E Carson
Journal:  J Nucl Med       Date:  2018-01-25       Impact factor: 10.057

9.  Botulinum neurotoxin type A inhibits synaptic vesicle 2 expression in breast cancer cell lines.

Authors:  C Bandala; A L Cortés-Algara; C M Mejía-Barradas; I Ilizaliturri-Flores; R Dominguez-Rubio; C I Bazán-Méndez; E Floriano-Sánchez; J P Luna-Arias; M Anaya-Ruiz; E Lara-Padilla
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

10.  A new role for the P2Y-like GPR17 receptor in the modulation of multipotency of oligodendrocyte precursor cells in vitro.

Authors:  Marta Boccazzi; Davide Lecca; Davide Marangon; Fabio Guagnini; Maria P Abbracchio; Stefania Ceruti
Journal:  Purinergic Signal       Date:  2016-08-20       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.